As show in Fig. 2a and B, GSK-3β inhibitor VII overtook the G1/S arrest of MCF10A cells treated with MG132, and detained cell cycle at G2/M phase (P = 0.001), similarly as tumor cells did in the presence of MG132 alone (see Fig. 1a). This evidence concerns the gene GSK3B and neoplasm.